PAMELA BADZINSKI: Open Payments
NPI 1831136118 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$536 in 30 payments from 16 companies in 2025. Trend: 2023 $1,105 · 2024 $566 · 2025 $536
Food & beverage: $536
| Company | Payments | Amount |
|---|---|---|
| Corium, LLC | 5 | $85 |
| Bausch Health US, LLC | 4 | $68 |
| Axsome Therapeutics, Inc. | 3 | $60 |
| ABBVIE INC. | 3 | $49 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $39 |
| Alkermes, Inc. | 2 | $35 |
| E.R. Squibb & Sons, L.L.C. | 2 | $33 |
| HARMONY BIOSCIENCES LLC | 1 | $25 |
| Neurocrine BioSciences, Inc. | 1 | $23 |
| Almatica Pharma LLC | 1 | $21 |
Products named: Azstarys, APLENZIN, VRAYLAR, Sunosi, CAPLYTA, LYBALVI, COBENFY, WAKIX.
Industry payments across FL — which companies pay providers there.
